Financial News
Headline News about Fusion Pharmaceuticals Inc
![](https://cdn.benzinga.com/files/images/story/2024/01/05/image26.jpeg?width=1200&height=800&fit=crop)
Why Dermata Therapeutics Shares Are Trading Higher By Over 57%; Here Are 20 Stocks Moving Premarket
January 05, 2024
Via Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-pre-market.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/01/02/image_3.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
A Closer Look at 4 Analyst Recommendations For Fusion Pharmaceuticals
December 27, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Recap: Fusion Pharmaceuticals Q1 Earnings
May 11, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/12/27/fusn.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/12/27/meta_platforms_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/12/20/fusn.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/11/21/image30.jpeg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
Fusion Pharmaceuticals's Return On Capital Employed Overview
December 06, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/12/26/image42.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/09/29/fusn.png?width=1200&height=800&fit=crop)
Fusion Pharmaceuticals Poised For Leadership In Targeted Cancer Therapies: Oppenheimer
September 29, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/06/23/fusn.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2023
September 29, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/02/14/image31.jpeg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 14, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/02/14/image18.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/02/14/image44.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
February 14, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/02/14/fusn_logo_light__83526ddca0fb5b1a5074ce97e744cfa4.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/02/14/image15.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-stock-market.jpg)
Benzinga's Top Ratings Upgrades, Downgrades For November 30, 2022
November 30, 2022
Via Benzinga
![](https://talkmarkets.com/images/logos/talkmarkets.png)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_3639.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_16972.jpeg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.